AGTC Genomics Hosts Selgate Healthcare and PrimeCare for Talks on Expanding Access to Precision Medicine in Malaysia

KUALA LUMPUR, MALAYSIA — When a genomic test could help explain a patient’s condition or guide a treatment decision, cost can put it out of reach. Patients may also be unsure where to get tested or who will help them understand the results. Clinicians need clear guidance on when to order a test, which test to choose and how to use the findings in patient care.
AGTC Genomics welcomed representatives from Selgate Healthcare and PrimeCare for a discussion on Malaysia’s precision medicine landscape and how the three organisations could work together to make these services more affordable and accessible. The visit focused on how to bring precision medicine into routine care, from the first consultation through to testing, counselling and follow-up.
Selgate Healthcare brings experience across an integrated healthcare ecosystem. It is the healthcare arm of Selgate Corporation, a wholly owned subsidiary of the Selangor State Development Corporation (PKNS). The group’s activities span specialist hospitals, primary care clinics, pharmacies, diagnostics, dental care, nursing and healthcare management.
Precision medicine combines information about a patient’s biology, including genomic findings where relevant, with their medical history and other clinical information. In cancer care, genomic testing can help identify treatment options for eligible patients. For some people with suspected inherited conditions, it can help clarify a diagnosis and guide follow-up for patients and their families.
Adopting precision medicine across Malaysia requires a healthcare system that can act on what sequencing reveals. Doctors need practical training in selecting tests, interpreting reports and discussing results with patients. Patients and families need clear information about what testing can tell them, what it costs and what happens after they receive their results. Clinics, hospitals and laboratories need clear referral pathways that connect patients to testing, genetic counselling and specialist care when needed. Healthcare providers and payers can help by exploring ways to lower out-of-pocket costs for clinically appropriate testing.
“A patient should be able to ask their doctor whether a genomic test could help, understand what it will cost and know who will guide them through the results,” said Prof. Chee-Onn Leong, Founder and CEO of AGTC Genomics. “Working with Selgate Healthcare and PrimeCare gives us an opportunity to address those questions where patients already receive care.”
AGTC Genomics sees opportunities to work with Selgate Healthcare and PrimeCare on clinician education, patient awareness and simpler referrals between primary care, specialist services and genomic laboratories. These efforts could help more patients access appropriate testing through the clinics and hospitals they already use, with support to understand the results and decide on the next step.
About AGTC Genomics
AGTC Genomics is a Malaysian genomics and precision medicine company headquartered in Bukit Jalil, Kuala Lumpur, serving healthcare providers, patients and research institutions across Malaysia and Southeast Asia. Its laboratory holds ISO 15189, ISO/IEC 17025 and College of American Pathologists (CAP) accreditations, supporting its commitment to quality and technical competence within its accredited scopes.
As a BioNexus Status company pioneering genomics technology, AGTC Genomics strengthens Malaysia’s capacity for advanced diagnostics and biotechnology innovation. Its offerings include MySTI-certified products and services recognised by the Ministry of Science, Technology and Innovation (MOSTI), highlighting locally developed capabilities that support the nation’s healthcare and innovation ambitions.
The company provides genomic testing across precision oncology, inherited disorders, pharmacogenomics, reproductive health and preventive healthcare, alongside research sequencing and bioinformatics services. By bringing together advanced technologies, clinical interpretation and genetic counselling, AGTC Genomics helps translate genomic information into informed healthcare decisions.
Through collaboration with hospitals, clinics, pharmacies, universities and industry partners, AGTC Genomics aims to make precision medicine more affordable and accessible, enabling more patients and families to benefit from personalised care.




Comments